AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2024 Issue 1; New/Revised ICD-10-PCS Codes: Section X – New Technology

Introduction of New Therapeutic Substances

In table XW0, Introduction of Anatomical Regions, substance value 2 Talquetamab Antineoplastic has been added to body part 1 Subcutaneous Tissue to identify the subcutaneous injection of TALVEY™, a bispecific T-cell engaging antibody that is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy. Bispecific antibodies (bsAbs) are a new class of drugs that can facilitate T-cell engagement without the need for patient cell collection and external manipulation.Section:           X  New Technology   Body System:  W...

To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .


  • The official AHA publication for ICD-10-CM and ICD-10-PCS coding guidelines and advice
  • Current newsletters added each quarter
  • Full Archives - over 3100 articles
  • ALL years/issues back to 1984 organized by year and issue
  • Includes ICD-10-CM/PCS Articles since 2013
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - ICD-10-CM/PCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.